Neutralizing GDF-15 Can Overcome Anti-PD-(L)1 Resistance in Solid Tumors

The development of immunotherapies has revolutionized cancer treatment, leveraging the body’s natural defense mechanisms to fight tumor cells. However, primary or acquired resistance to these therapies remains a critical challenge, with a significant medical need for new approaches that can help to overcome this major obstacle in immune-oncology.